Lacosamide Neuraxpharm (Lacosamide)

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This action stabilises hyperexcitable neurons, reduces repetitive firing, and thereby diminishes the likelihood of seizure propagation.

The dosage of Lacosamide Neuraxpharm is individualized by the prescribing clinician based on the patient’s clinical response, tolerability, and other medical considerations. Specific dosing regimens are determined by the treating physician.

Safety data for lacosamide in pregnancy are limited, and the pregnancy category is listed as unknown. It should be used only if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider for guidance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with other sodium‑channel antiepileptics such as carbamazepine, lacosamide uniquely targets the slow inactivation phase of the channel, which may offer efficacy with a different side‑effect profile. The choice between agents depends on individual patient characteristics, comorbidities and physician judgment.

Store the product at ambient temperature below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and do not refrigerate or freeze the tablets.

Lacosamide Neuraxpharm is supplied as an oral tablet intended for swallowing with water. The prescribing physician determines the dosing frequency and whether it should be taken with or without food.

Serious adverse events include cardiac conduction abnormalities (such as PR‑interval prolongation), severe skin reactions like Stevens‑Johnson syndrome, suicidal thoughts or behavior, and rare cases of liver injury. Patients should seek immediate medical attention if any of these symptoms develop.

Individuals with a known hypersensitivity to lacosamide or any of its excipients, patients with significant cardiac conduction disorders, and those for whom the prescriber determines that the risks outweigh the benefits should avoid using this medication.